本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akoya Biosciences, Inc.

1.32
+0.02001.54%
盘后1.26-0.0600-4.55%18:11 EDT
成交量:53.07万
成交额:72.17万
市值:6,583.55万
市盈率:-1.38
高:1.38
开:1.30
低:1.30
收:1.30
数据加载中...
2025/02/25

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/25

重要事件披露

Form 8-K - Current report
2025/02/25

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/11

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/16

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/16

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/15

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/14

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/10

重要事件披露

Form 8-K - Current report
2025/01/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/12/13

重要事件披露

Form 8-K - Current report
2024/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/15

重要事件披露

Form 8-K - Current report
2024/11/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/04

重要事件披露

Form 8-K - Current report
2024/08/28

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]